Profile: Amorcyte, Inc. is a biotechnology company developing cell therapy products to treat cardiovascular disease. Our autologous bone marrow derived, CD34 positive selected stem cell product, AMR-001 limits the damage of heart muscle that develops following AMI and, thus, has the potential to limit ventricular remodeling.